SPROUTY, A WT1 TARGET FOR GROWTH AND DEVELOPMENT
SPROUTY, A WT1 TARGET FOR GROWTH AND DEVELOPMENT
批准号:
6840848
负责人:
Jonathan D. Licht
金额:
$32.23万
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-01-01 至 2005-12-31
关键词:
Wilms&apos tumorcadherinscell differentiationclinical researchdevelopmental geneticsenzyme activityfibroblast growth factorgene targetinggenetically modified animalshuman subjectinhibitor /antagonistlaboratory mousemitogen activated protein kinaseneoplasm /cancer geneticsposttranslational modificationsprotein tyrosine kinasetumor suppressor genestumor suppressor proteins
中文摘要
描述:(改编自申请人的摘要)
在这个方案中,我们将描述Sprouty在肾脏中的表达
发育、小鼠发育和肾母细胞瘤。我们会
描述发芽的作用机制。因此我们将确定是否
Sprouty是一种生长抑制因子,可能参与WT1的部分作用。我们
将决定通过受体酪氨酸激酶传递信号的步骤
斯普鲁蒂表演。然后我们分离SPRY的配对蛋白,这将导致
对发芽的分子机制有更好的了解。为了确定
SPRY在正常和异常发育中的作用我们将在细胞中确定
SPRY基因工程表达的培养模型和转基因动物
干扰正常的肾脏形态发生。最后,提供一个关键角色
作为WT1的目标,芽对肾脏发育很重要,我们将创建
利用条件克隆技术将动物淘汰为发芽动物。穿过
在这些研究中,我们将描述一种与isgnal有关的令人兴奋的分子。
转导与发育。SPRY可能会成为未来战略的目标
治疗肾母细胞瘤、其他恶性肿瘤和多囊肾等肾脏疾病
肾脏疾病。
英文摘要
DESCRIPTION: (Adapted from the applicant's abstract)
In this proposal we will characterize the expression of sprouty in renal
development, murine development in general and in Wilm's tumors. We will
characterize the mechanism of action of sprouty. Hence we will determine if
sprouty is a growth inhibitor which may mediate some of the effects of WT1. We
will determine at which steo in signaling through receptor tyrosine kinase
sprouty acts. We then isolate partner proteins of spry which will lead to
better idea of the molecular mechanism of sprouty. In order to determine the
role of spry in normal and aberrant development we will determine in cell
culture models and transgenic animals if engineered expression of spry
interferes with normal renal morphogenesis. Finally to provide a critical role
of sprouty as a target of WT1 important for renal development we will create
knockout animals for sprouty one using conditiona cre-lox technology. Through
these studies we will characterize an exciting molecule involved isgnal
transduction and development. Spry may present a target for future strategies
against Wilm's tumor, other malignancies and renal disorder such as polycystic
kidney disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Exploring microRNA degradation in T-cell acute lymphoblastic leukemia
-
批准号:10717486
-
项目类别:
-
资助金额:$50.38万
-
财政年份:2023
-
负责人:Jonathan D. Licht
-
依托单位:
UF Health Cancer Center Support Grant - Training Navigator Supplement
-
批准号:10892335
-
项目类别:
-
资助金额:$19.59万
-
财政年份:2023
-
负责人:Jonathan D. Licht
-
依托单位:
University of Florida Health Cancer Center Support Grant
-
批准号:10625750
-
项目类别:
-
资助金额:$213.5万
-
财政年份:2023
-
负责人:Jonathan D. Licht
-
依托单位:
Developmental Funds
-
批准号:10625759
-
项目类别:
-
资助金额:$30.5万
-
财政年份:2023
-
负责人:Jonathan D. Licht
-
依托单位:
Leadership, Planning, and Evaluation
-
批准号:10625761
-
项目类别:
-
资助金额:$42.28万
-
财政年份:2023
-
负责人:Jonathan D. Licht
-
依托单位:
Defining and targeting epigenetic plasticity-driven drug resistance and immune escape in melanoma
-
批准号:10666665
-
项目类别:
-
资助金额:$47.85万
-
财政年份:2022
-
负责人:Jonathan D. Licht
-
依托单位:
KDM6A mutation as an epigenetic driver of multiple myeloma
-
批准号:10229675
-
项目类别:
-
资助金额:$5.7万
-
财政年份:2020
-
负责人:Jonathan D. Licht
-
依托单位:
2019 Cancer Genetics and Epigenetics GRC/GRS
-
批准号:9754282
-
项目类别:
-
资助金额:$0.4万
-
财政年份:2019
-
负责人:Jonathan D. Licht
-
依托单位:
The Role of MMSET in the Pathogenesis and Progression of Lymphoid Malignancy
-
批准号:9330809
-
项目类别:
-
资助金额:$34.88万
-
财政年份:2016
-
负责人:Jonathan D. Licht
-
依托单位:
The Role of MMSET in the Pathogenesis and Progression of Lymphoid Malignancy
-
批准号:9759647
-
项目类别:
-
资助金额:$33.84万
-
财政年份:2016
-
负责人:Jonathan D. Licht
-
依托单位:
Spatio-Temporal Organization of Chromatin and Information Transfer in Cancer
-
批准号:8866966
-
项目类别:
-
资助金额:$198.95万
-
财政年份:2015
-
负责人:Jonathan D. Licht
-
依托单位:
Project 2: Molecular Modulation of Chromatin and Nuclear Structure in Cancer
-
批准号:8866971
-
项目类别:
-
资助金额:$52.07万
-
财政年份:2015
-
负责人:Jonathan D. Licht
-
依托单位:
Spatio-Temporal Organization of Chromatin and Information Transfer in Cancer
-
批准号:9070573
-
项目类别:
-
资助金额:$207.45万
-
财政年份:2015
-
负责人:Jonathan D. Licht
-
依托单位:
UTX, MLL and Pathogenic Deregulation of Histone Methylation in Multiple Myeloma
-
批准号:8916053
-
项目类别:
-
资助金额:$5.14万
-
财政年份:2014
-
负责人:Jonathan D. Licht
-
依托单位:
UTX, MLL and Pathogenic Deregulation of Histone Methylation in Multiple Myeloma
-
批准号:8775116
-
项目类别:
-
资助金额:$37.3万
-
财政年份:2014
-
负责人:Jonathan D. Licht
-
依托单位:
UTX, MLL AND PATHOGENIC DEREGULATION OF HISTONE METHYLATION IN MULTIPLE MYELOMA
-
批准号:9353181
-
项目类别:
-
资助金额:$34.74万
-
财政年份:2014
-
负责人:Jonathan D. Licht
-
依托单位:
Transcriptional Functions and Targets of the MMSET Protein of t(4:14) Myeloma
-
批准号:7754697
-
项目类别:
-
资助金额:$31.64万
-
财政年份:2009
-
负责人:Jonathan D. Licht
-
依托单位:
Transcriptional Functions and Targets of the MMSET Protein of t(4:14) Myeloma
-
批准号:8206815
-
项目类别:
-
资助金额:$30.69万
-
财政年份:2009
-
负责人:Jonathan D. Licht
-
依托单位:
Transcriptional Functions and Targets of the MMSET Protein of t(4:14) Myeloma
-
批准号:7583854
-
项目类别:
-
资助金额:$31.64万
-
财政年份:2009
-
负责人:Jonathan D. Licht
-
依托单位:
Transcriptional Functions and Targets of the MMSET Protein of t(4:14) Myeloma
-
批准号:8403653
-
项目类别:
-
资助金额:$28.85万
-
财政年份:2009
-
负责人:Jonathan D. Licht
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于“Healthy-NAT-Tumor”三维度的食管鳞癌蛋白组学数据挖掘及其临床意义研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:刘伟
-
依托单位:
超级增强子驱动“CYTOR-FOSL1正反馈环路”促进口腔鳞癌Tumor budding转移的研究
-
批准号:82073265
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:王成
-
依托单位:
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
-
批准号:82072862
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2020
-
负责人:徐云升
-
依托单位:
STAU1/TP63信号轴介导TINCR调控舌鳞癌tumor budding细胞干性维持
-
批准号:81802704
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:庄泽航
-
依托单位:
基于tumor cord-PBPK偶联模型的抗肿瘤药物药动学预测研究
-
批准号:81703454
-
项目类别:青年科学基金项目
-
资助金额:20.1万元
-
批准年份:2017
-
负责人:吴春暖
-
依托单位:
SUZ12 ceRNAs参与miR-320a调控舌鳞癌tumor budding侵袭转移的分子机制
-
批准号:81602380
-
项目类别:青年科学基金项目
-
资助金额:17.0万元
-
批准年份:2016
-
负责人:谢楠
-
依托单位:
FOSL1 ceRNA网络调控舌鳞癌Tumor Budding细胞侵袭转移的分子机制
-
批准号:81572661
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2015
-
负责人:王成
-
依托单位: